Aptadel Therapeutics is a preclinical-stage biotech company located in Barcelona, Spain.
We are developing an RNA-based delivery platform for cancer treatment. The platform is based on Aptamer technologies. Our lead indication is Ewing Sarcoma, a rare variety of bone cancer, affecting children.
Company Details
- Employees
- 8
- Founded
- 2020
- Address
- Barcelona, Es
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.aptadeltx.com
- Keywords
- groundbreaking research.
- HQ
- Barcelona
Aptadel Therapeutics Questions
Aptadel Therapeutics's website is http://www.aptadeltx.com
Aptadel Therapeutics's LinkedIn profile is https://es.linkedin.com/company/aptadel-therapeutics
Aptadel Therapeutics has
8 employees.
View email and phone details for 8
employees at Aptadel Therapeutics.
Aptadel Therapeutics's industry is
Biotechnology Research
Aptadel Therapeutics's top competitors are
Onechain Immunotherapeutics,
Rejuversen,
Nuage Therapeutics,
Nimble Diagnostics,
Mjn-Neuro,
The Blue Box Biomedical Solutions,
Ona Therapeutics,
Mimark Diagnostics,
Minoryx Therapeutics,
Splicebio.
Aptadel Therapeutics's categories are Biotechnology Research
Aptadel Therapeutics's founding year is 2020
